Growth Metrics

Cresco Labs (CRLBF) Cost of Revenue (2020 - 2026)

Cresco Labs filings provide 7 years of Cost of Revenue readings, the most recent being $75.9 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 12.91% to $75.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $320.0 million, a 9.83% decrease, with the full-year FY2025 number at $331.3 million, down 7.95% from a year prior.
  • Cost of Revenue hit $75.9 million in Q1 2026 for Cresco Labs, down from $78.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $111.9 million in Q4 2022 to a low of $75.9 million in Q1 2026.
  • Median Cost of Revenue over the past 5 years was $92.1 million (2024), compared with a mean of $94.8 million.
  • Biggest five-year swings in Cost of Revenue: increased 5.49% in 2023 and later fell 19.43% in 2024.
  • Cresco Labs' Cost of Revenue stood at $111.9 million in 2022, then fell by 17.68% to $92.1 million in 2023, then dropped by 0.23% to $91.9 million in 2024, then decreased by 14.86% to $78.2 million in 2025, then dropped by 3.01% to $75.9 million in 2026.
  • The last three reported values for Cost of Revenue were $75.9 million (Q1 2026), $78.2 million (Q4 2025), and $85.6 million (Q3 2025) per Business Quant data.